February 17, 2025
Why melanoma cells escape the eye and how to potentially stop themUIC researchers develop a new peptide to prevent metastatic ocular melanoma
January 28, 2025
How UIC scientists redesigned an effective cancer therapy to make it saferRedesigned enzyme may prevent side effects in treating leukemia, be effective against other cancers
October 17, 2023
Multi-omics approach unlocks discovery of natural products from bacteriaCollege of Pharmacy researchers discovered potential new compounds for synthetic biology
October 25, 2022
New enzyme inhibitor shows promise for treating cancers, autoimmune diseasesDiscovery reported in the journal Angewandte Chemie
July 28, 2022
Paul Carlier joins UIC as director of UICentre and professor of pharmaceutical sciencesPaul Carlier to join UIC Aug. 16
January 19, 2022
‘Decoy’ protein works against multiple SARS-CoV-2 variantsStudy results are reported in the journal Nature Chemical Biology
July 28, 2021
UIC awarded $6 million to develop potential COVID-19 treatmentU.S. Department of Defense grant supports pre-clinical research studies
February 8, 2021
New drug target for Ebola, Marburg virusesUIC research published in PLOS Pathogens
August 27, 2020
Phase 1 human trials suggest UIC-developed breast cancer drug is safe, effectiveResults published in Breast Cancer Research and Treatment